The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -39.91%.However, over the last six months, we can see a stronger performance of -18.11%. Over the last 30 days, the price of ZOM has leaped by -6.31%. And in the last five days, it has fallen by -3.99%.
Zomedica Corp’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $0.22 on 01/02/24 and a low of $0.12 for the same time frame on 11/08/24.
52-week price history of ZOM Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Zomedica Corp’s current trading price is -44.87% away from its 52-week high, while its distance from the 52-week low is 2.82%. The stock’s price range during this period has varied between$0.12 and $0.22. The Zomedica Corp’s shares, which operate in the Healthcare, saw a trading volume of around 3.22 million for the day, a figure considerably lower than their average daily volume of 5.33 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Zomedica Corp (ZOM) has experienced a quarterly decline of -12.32% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 117.89M and boasts a workforce of 144 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.1290, with a change in price of -0.0259. Similarly, Zomedica Corp recorded 4,594,015 in trading volume during the last 100 days, posting a change of -17.61%.
ZOM’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ZOM stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.
ZOM Stock Stochastic Average
As of today, Zomedica Corp’s raw stochastic average for the last 50 days stands at 11.11%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 18.82%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 18.43% and 16.14%, respectively.
